Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02572973 · ClinicalTrials.gov registry record · NA
Acoustic Neuromodulation (ANM) for Youth With Anxiety Disorders
A NA study, sponsored by Weill Medical College of Cornell University.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT02572973 is a NA study that was terminated before completion, run by Weill Medical College of Cornell University. The registered enrollment target is 6 participants.
The verdict
NCT02572973, a NA study, was terminated before completion, sponsored by Weill Medical College of Cornell University.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The acoustic neuromodulation trial (ANM-T) is a two-phase, single-site, pilot randomized clinical trial examining the feasibility of completing a larger scale efficacy study of a novel treatment of non-linear modulated acoustic stimuli to reduce anxiety severity in youth with anxiety disorders. The primary objective is to establish the feasibility of a blinded randomized controlled trial of ANM for childhood anxiety disorders.
Interventions
- OTHER Acoustic Neuromodulation (ANM)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2014-07 |
| Est. Completion | 2016-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02572973
The ClinicalTrials.gov registry entry for NCT02572973 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Acoustic Neuromodulation (ANM) is the first listed.
NCT02572973 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02572973 about?
NCT02572973 is a clinical study titled "Acoustic Neuromodulation (ANM) for Youth With Anxiety Disorders". The acoustic neuromodulation trial (ANM-T) is a two-phase, single-site, pilot randomized clinical trial examining the feasibility of completing a larger scale efficacy study of a novel treatment of non-linear modulated acoustic stimuli to reduce anxiety severity in youth with anxiety disorders. The ...
What is the current status of trial NCT02572973?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2014-07. Estimated completion is 2016-04.
What interventions are being tested in trial NCT02572973?
The interventions under investigation include: Acoustic Neuromodulation (ANM) (OTHER).
Who is sponsoring clinical trial NCT02572973?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.